Article
MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer.
Cancer science - 1 Mar 2022
Yamasaki Juntaro, Hirata Yuki, Otsuki Yuji, Suina Kentaro, Saito Yoshiyuki, Masuda Kenta, Okazaki Shogo, Ishimoto Takatsugu, Saya Hideyuki, Nagano Osamu
Abstract excerpt
Metastatic progression of tumors is driven by genetic alterations and tumor-stroma interaction. To elucidate the mechanism underlying the oncogene-induced gastric tumor progression, we have developed an organoid-based model of gastric cancer from GAstric Neoplasia (GAN) mice, which express Wnt1 and the enzymes COX2 and microsomal prostaglandin E synthase 1 in the stomach. Both p53 knockout (GAN-p53KO) organoids...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
